Cargando…

Hydroxamic Acid Derivatives: From Synthetic Strategies to Medicinal Chemistry Applications

[Image: see text] Since the approval of three hydroxamic acid-based HDAC inhibitors as anticancer drugs, such functional groups acquired even more notoriety in synthetic medicinal chemistry. The ability of hydroxamic acids (HAs) to chelate metal ions makes this moiety an attractive metal binding gro...

Descripción completa

Detalles Bibliográficos
Autores principales: Citarella, Andrea, Moi, Davide, Pinzi, Luca, Bonanni, Davide, Rastelli, Giulio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412920/
https://www.ncbi.nlm.nih.gov/pubmed/34497879
http://dx.doi.org/10.1021/acsomega.1c03628
Descripción
Sumario:[Image: see text] Since the approval of three hydroxamic acid-based HDAC inhibitors as anticancer drugs, such functional groups acquired even more notoriety in synthetic medicinal chemistry. The ability of hydroxamic acids (HAs) to chelate metal ions makes this moiety an attractive metal binding group—in particular, Fe(III) and Zn(II)—so that HA derivatives find wide applications as metalloenzymes inhibitors. In this minireview, we will discuss the most relevant features concerning hydroxamic acid derivatives. In a first instance, the physicochemical characteristics of HAs will be summarized; then, an exhaustive description of the most relevant methods for the introduction of such moiety into organic substrates and an overview of their uses in medicinal chemistry will be presented.